contributions < control < controlled

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 58.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2011)	Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]	Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000017 (2011)	Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]	Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000027 (2010)	Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon]	Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
000036 (2013)	Ruchika Goel [Inde] ; Debashish Danda [Inde] ; Sathish Kumar [Inde] ; George Joseph [Inde]	Rapid control of disease activity by tocilizumab in 10 ‘difficult‐to‐treat’ cases of Takayasu arteritis
000050 (2011)	Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru Harada	Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000051 (2008)	Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi	Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary
000080 (2012)	M. Licht [Allemagne] ; U. Kyank [Allemagne] ; C. Kneitz [Allemagne]	Therapierefraktäre Polyarthritis und Fieber
000092 (2009)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]	Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
000095 (2009)	Paul Emery ; Rhonda Siddall	Tocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis
000133 (2009)	Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]	Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000141 (2011)	H. Bastian [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Therapiestrategien bei rheumatoider Arthritis
000155 (2009)	Misato Hashizume [Japon] ; Naohiko Hayakawa [Japon] ; Miho Suzuki [Japon] ; Masahiko Mihara [Japon]	IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
000235 (2010)	Manjari Lahiri [Singapour] ; Gim-Gee Teng [Singapour]	A case of refractory adult‐onset Still’s disease treated with anakinra
000289 (2013)	Andrew Stone [Royaume-Uni] ; Christy Chuang-Stein [États-Unis]	Strong control over multiple endpoints: are we adding value to the assessment of medicines?
000322 (2007)	M. Feuchtenberger [Allemagne] ; C. Kneitz [Allemagne] ; H.-P. Tony [Allemagne]	Zytokine
000453 (2008)	Katsuaki Kanbe [Japon] ; Kazuhiko Inoue [Japon] ; Yasuo Inoue [Japon] ; Yutaka Suzuki [Japon]	Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis
000674 (2013)	Christoph Fiehn [Allemagne] ; Elisabeth Belke-Voss [Allemagne] ; Dietmar Krause [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Rolf Rau [Allemagne]	Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs
000677 (2013)	K. Kume ; K. Amano ; S. Yamada ; T. Kanazawa ; H. Komori ; K. Hatta ; K. Amano [Japon]	FRI0252 Tocilizumab improves arterial stiffness in rheumatoid arthritis irrespective of its disease activity control effects
000701 (2008)	B. Manger [Allemagne]	Der adulte Morbus Still
000722 (2013)	Geoffrey Littlejohn [Australie, États-Unis] ; Lynden Roberts [Australie] ; Mark Arnold [Australie] ; Paul Bird [Australie] ; Simon Burnet [Australie] ; Julien De Jager [Australie] ; Hedley Griffiths [Australie] ; Dave Nicholls [Australie] ; James Scott [Australie] ; Jane Zochling [Australie] ; Kathleen E. Tymms [Australie]	A multi‐center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control
000793 (2011)	Sheila L. Arvikar [États-Unis] ; Mark C. Fisher [États-Unis]	Inflammatory bowel disease associated arthropathy

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "control" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "control" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    control
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021